Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Coacillium - Legacy Healthcare

Next Previous
Drug Profile

Coacillium - Legacy Healthcare

Alternative Names: Cinainu - Legacy Healthcare; Coacillium cutaneous solution - Legacy Healthcare; Coacillium oral solution - Legacy Healthcare; Coacillium topical solution - Legacy Healthcare; Coacillium®; LH-10; LH-4; LH-8; LH8 - Legacy Healthcare; Topical Coacillium 21%; Topical Coacillium 42%

Latest Information Update: 12 Jan 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Legacy Healthcare
  • Class Anti-inflammatories; Antipsoriatics; Skin disorder therapies
  • Mechanism of Action E-Selectin expression inhibitors; Intercellular adhesion molecule-1 expression inhibitors; Interleukin-8 expression inhibitors; Ki-67 antigen expression stimulants; Proto-oncogene protein c-bcl-2 expression stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preregistration Alopecia areata
  • Phase II Alopecia
  • Phase I Fatigue
  • Research Atopic dermatitis; Psoriasis

Most Recent Events

  • 06 Jan 2026 Legacy Healthcare announces intention to submit NDA to USFDA in Alopecia areata
  • 06 Jan 2026 Legacy Healthcare plans a phase III RAAINBOW-2 trial for Alopecia areata (In Children, In Adolescents) in USA and Japan
  • 09 Sep 2025 Phase-I clinical trials in Fatigue (PO) (Legacy Healthcare pipeline, September 2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top